CLOSE X
GO

Mirae Asset Healthcare Fund-Reg(G)

very highequitypharma & health care
37.29 0.36(0.97%) NAV as on 05 Feb 2025
-6.06 % 1 M
23.46 % 1 Y
17.81 % 3 Y

Growth Chart of the Scheme vis a vis benchmark (SIP value 10,000)

  • 1M
  • 3M
  • 6M
  • 1Y
  • 3Y
  • 5Y
  • 10Y
  • max

FUND OBJECTIVE

The investment objective of the scheme is to seek to generate long term capital appreciation through investing in equity and equity related securities of companies benefitting directly or indirectly in Healthcare and allied sectors in India. The Scheme does not guarantee or assure any returns.

SCHEME DETAILS

expense_ration-icon Expenses Ratio :

1.92

As on 31 Dec, 2024
age-icon Age :

6 yrs 7 m

Since 02 07 ,2018
exit_load Exit Load :

1%

aum AUM :

2,863.52 Crs

lock_in Lock-in :

1% on or before 1Y(365D), Nil after 1Y(365D)

investing_style Investing Style :

Large Growth

Portfolio_book_value Portfolio Price To Book Value :

6.91

Min_Investment Min. Investment :

SIP 99 & Lumpsum 5000

Scheme_benchmark Scheme Benchmark :

BSE HEALTH CARE - TRI

Fund_manager Fund Manager :

Vrijesh Kasera

LATEST ASSET & PORTFOLIO ALLOCATION

as on Dec 31 ,2024
Others 0.79 %
Equity 99.21 %

TOP HOLDINGS

Sun Pharmaceutical Industries...11.84 %
Aurobindo Pharma Ltd.7.62 %
Cipla Ltd.6.82 %
Dr. Reddy's Laboratories Ltd.6.38 %
Lupin Ltd.5.99 %
See All Holding

ALLOCATION BY MARKET CAP

ALLOCATION BY SECTOR

Pharmaceuticals & Drugs80.84
Hospital & Healthcare Services12.83
Business Support4.19
Chemicals1.34
See All Sectors

5-YEARS HISTORY

Financial Year2020-20212021-20222022-20232023-20242024-2025
NAV in Rs (as on 04-Feb-2025)18.7722.3820.1231.1436.93
Net Assets(Rs Crores) (as on 04-Feb-2025) 1268.97 1817.47 1513.40 2235.15 2863.52
Scheme Returns(%)(Absolute)79.3118.45-9.8954.7417.35
B'mark Returns(%)(Absolute)NANANANANA
Category Rank27/7534/7569/7623/9016/98

RISKOMETER Level of Risk in the Scheme

Investors understand that their principal will be at very high risk

PERFORMANCE COMPARISON WITH SIMILAR SCHEMES

Mirae Asset Healthcare Fund-Reg(G)Very HighEquity37.290.36(0.97%)NAV As on 05 Feb, 202502-Jul-2018Inception Date2,863.52AUM In Cr.23.46%1Y17.81%3Y26.59%5Y22.06%Since Inception
SBI Healthcare Opp Fund-Reg(G)Very HighEquity422.096.90(1.66%)NAV As on 05 Feb, 202514-Jul-1999Inception Date3,628.03AUM In Cr.29.31%1Y23.55%3Y27.76%5Y16.50%Since Inception
ICICI Pru Pharma Healthcare & Diagnostics (P.H.D) Fund-(G)Very HighEquity37.700.25(0.67%)NAV As on 05 Feb, 202513-Jul-2018Inception Date5,320.29AUM In Cr.29.73%1Y23.52%3Y28.42%5Y22.37%Since Inception
Tata India Pharma & Healthcare Fund-Reg(G)Very HighEquity30.020.30(1.02%)NAV As on 05 Feb, 202528-Dec-2015Inception Date1,287.45AUM In Cr.24.45%1Y20.41%3Y25.45%5Y12.82%Since Inception
ATTENTION INVESTORS NSDL/CDSL KYC Advisory for investors